Patents by Inventor Fabien Calvo

Fabien Calvo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptides for the Treatment of Angiogenesis or Lymphangiogenesis-Related Diseases
    Publication number: 20170313758
    Abstract: The present invention relates to polypeptides for the treatment of angiogenesis or lymphangiogenesis-related diseases. In particular, the present invention relates to a a polypeptide which comprises or consists of a sequence of at least 5 consecutive amino acids in SEQ ID NO: 1 and which comprises at least one amino acid selected from the group consisting of Q182, R184, Q195, T199.
    Type: Application
    Filed: November 24, 2015
    Publication date: November 2, 2017
    Inventors: Samia Mourah, Bruno Villoutreix, Farah Khayati, Suzanne Menashi, Celeste Lebbe, Juan Fernandez Recio, Fabien Calvo
  • Method for selectively quantifying VEGF isoforms in a biological sample and uses thereof
    Patent number: 8530162
    Abstract: The present invention pertains to a novel method for quantifying VEGF various isoforms in a biological sample, with a very high selectivity and sensitivity. It also concerns a method for establishing a diagnostic and/or a prognosis concerning a patient potentially suffering from cancer, diabetes, or cardiovascular disease, comprising a step of determining the level of at least one of the VEGF isoforms, in a biological sample from said patient.
    Type: Grant
    Filed: June 14, 2005
    Date of Patent: September 10, 2013
    Assignees: INSERM (Institut National de la Santa et de la Recherche Medicale), Assistance Publique-Hopitaux de Paris
    Inventors: Fabien Calvo, Samia Mourah, Benyoussef Naimi
  • Method for Selectively Quantifying Vegf Isoforms in a Biological Sample and Uses Thereof
    Publication number: 20100167273
    Abstract: The present invention pertains to a novel method for quantifying VEGF various isoforms in a biological sample, with a very high selectivity and sensitivity. It also concerns a method for establishing a diagnostic and/or a prognosis concerning a patient potentially suffering from cancer, diabetes, or cardiovascular disease, comprising a step of determining the level of at least one of the VEGF isoforms, in a biological sample from said patient.
    Type: Application
    Filed: June 14, 2005
    Publication date: July 1, 2010
    Applicants: INSERM (INST.NAT. DE LA SANTE ET DE LA RECH. MED.), ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS
    Inventors: Fabien Calvo, Samia Mourah, Benyoussef Naimi
  • Process aimed at evidencing the state of a malignant cell
    Patent number: 6277575
    Abstract: The malignant or otherwise diseased state of a cell can be determined in tissues fixed by techniques such as the formalin and parafin methods. This determination is made by (1) studying the precise conformation (i.e. position and structure) of at least one gene within a chromosome of a targeted cell and (2) measuring the deviation of gene conformation in comparison to a non-diseased cell. Accordingly, methods for evaluating the malignancy index of cells, as well as monitoring the effectiveness of therapeutic treatment, are provided.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: August 21, 2001
    Inventor: Fabien Calvo